Date | Title | Description | Source |
12.04.2024 | Biomerica Reports Third Quarter 2024 Financial Results | Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Fo... | einpresswi... |
10.11.2023 | Biomerica to Participate in 14th Annual Craig-Hallum Alpha S... | IRVINE, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a ... | einpresswi... |
14.04.2023 | Biomerica Reports Q3 Fiscal 2023 Results | For the nine months ended February 28, 2023 vs. the same period in 2022, revenues, excluding sales o... | einpresswi... |
14.04.2023 | Biomerica Reports Q3 Fiscal 2023 Results | For the nine months ended February 28, 2023 vs. the same period in 2022, revenues, excluding sales o... | einpresswi... |
07.03.2023 | Biomerica Announces Closing of $8 Million Underwritten Publi... | IRVINE, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. BMRA ("Biomerica"), a g... | einpresswi... |
02.03.2023 | Biomerica Announces Proposed Underwritten Public Offering of... | /EIN News/ -- IRVINE, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Bi... | einpresswi... |
13.01.2023 | Biomerica Reports Financial Results for Fiscal 2023 Second Q... | InFoods® IBS Data Receives American College of Gastroenterology Presidential Award (ACG) Following P... | einpresswi... |
08.12.2022 | Biomerica Receives KFDA and Ministry of Health Approval for ... | Expands Commercialization Efforts in Areas with High Unmet Needs
/EIN News/ -- IRVINE, Calif., Dec. ... | einpresswi... |
13.10.2022 | Biomerica Reports 30% Increase in Revenues for Fiscal Q1 202... | Notice of Patent Allowance in Australia containing broad claims pertaining to treating ADD/ADHD usin... | globenewsw... |
13.10.2022 | Biomerica Reports 30% Increase in Revenues for Fiscal Q1 202... | Notice of Patent Allowance in Australia containing broad claims pertaining to treating ADD/ADHD usin... | einpresswi... |
30.08.2022 | Biomerica Plans Launch of InFoods® IBS Test; Names Robert Ca... | InFoods® IBS commercial launch and revenues expected before the close of calendar year 2022
Mr. Carl... | globenewsw... |
29.08.2022 | Biomerica Reports Fiscal 2022 Year End Results | Revenues increase 162% for fiscal 2022 vs fiscal 2021
Revenues for fiscal Q4 2022 up 403% vs. fiscal... | globenewsw... |
12.05.2022 | Biomerica Announces CE Mark for Its H. pylori Diagnostic Tes... | - Attaining CE Mark is a major step toward commercialization –
- World Health Organization (WHO) lis... | globenewsw... |
26.04.2022 | Biomerica Announces FDA Submission For a Test to Detect Heli... | Gastric cancer is the third most common cause of cancer related death in the world and over 80% of g... | globenewsw... |
13.01.2022 | Biomerica Reports Record Financial Results for Fiscal Second... | Revenues up 239% over prior year fiscal second quarter
Customer orders backlog of over $4.0 million ... | globenewsw... |
16.12.2021 | Biomerica Announces Preliminary Second Quarter Revenue Incre... | InFoods® IBS Clinical Trial on Track for Completion in December with Topline Results Expected to be ... | marketscre... |
16.12.2021 | Biomerica : Announces Preliminary Second Quarter Revenue Inc... | Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to approximat... | marketscre... |
16.12.2021 | Biomerica Announces Preliminary Second Quarter Revenue Incre... | InFoods® IBS Clinical Trial on Track for Completion in December with Topline Results Expected to be ... | globenewsw... |
04.11.2021 | Biomerica Receives Notice of Allowance from Canadian Patent ... | Studies show that 13-20% of Canadians suffer from IBS at any given time1.
The lifetime risk for a Ca... | globenewsw... |
15.10.2021 | Biomerica Reports Results for Fiscal First Quarter ended Aug... | Revenues up 10% over fiscal first quarter 2021, and 20% over fiscal fourth quarter 2021
Customer ord... | globenewsw... |
28.08.2021 | Biomerica Reports Fiscal 2021 Year End Results | Revenues increase 7.6% for fiscal 2021 vs fiscal 2020.
InFoods® IBS Endpoint Trial expected to be fu... | marketscre... |
24.06.2021 | Biomerica Signs Exclusive Distribution Agreement in Canada f... | Prevalence of H. pylori infection in the United States is approximately 35% to 40% of the population... | marketscre... |
15.06.2021 | BIOMERICA, INC.
Biomerica Receives Notice of Allowance from... | IBS is one of the most important gastrointestinal disorders in Mexico, with a prevalence of around 1... | marketscre... |
11.05.2021 | BIOMERICA, INC.
Biomerica's Fast 15-Minute Easy to Use COVI... | Less invasive nasal swab taken from front opening of the nose is more comfortable for patients
Test ... | marketscre... |
15.04.2021 | BIOMERICA, INC.
Biomerica Reports 208% Increase In Q3 Fisca... | Sales increase driven by first sales of COVID-19 Antigen Rapid Test in Europe after January 2021 CE ... | marketscre... |
06.09.2011 | The MassDevice Weekly Checkup: Sept. 6, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. cluster... | massdevice... |
29.08.2011 | The MassDevice Weekly Checkup: August 29, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. cluster... | massdevice... |
25.07.2011 | The MassDevice Weekly Checkup: July 25, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. cluster... | massdevice... |
27.06.2011 | The MassDevice Weekly Checkup: June 27, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. cluster... | massdevice... |
08.03.2011 | The MassDevice Weekly Checkup: March 8, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. cluster... | massdevice... |
22.02.2011 | The MassDevice Weekly Checkup: February 22, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. cluster... | massdevice... |
01.02.2011 | The MassDevice Weekly Checkup: February 1, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. cluster... | massdevice... |
18.01.2011 | The MassDevice Weekly Checkup: January 18, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. cluster... | massdevice... |
05.01.2011 | The MassDevice Weekly Checkup: January 5, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. cluster... | massdevice... |
31.08.2010 | The MassDevice Weekly Checkup: August 31, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. cluster... | massdevice... |
29.06.2010 | The MassDevice Weekly Checkup: June 29, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. cluster... | massdevice... |
15.06.2010 | The MassDevice Weekly Checkup: June 15, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. cluster... | massdevice... |
02.06.2010 | The MassDevice Weekly Checkup: June 1, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. cluster... | massdevice... |
10.03.2010 | The MassDevice Weekly Checkup: March 9, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. cluster... | massdevice... |
22.02.2010 | The MassDevice Weekly Checkup: February 23, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. cluster... | massdevice... |
29.12.2009 | Annual Checkup: The gainers and losers in medical device sto... | All year our Weekly Checkup calculated the biggest gainers and losers among publicly traded medical ... | massdevice... |